Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-02-23

FDA Approved: VALACYCLOVIR — Supplemental Application (Quallent Pharmaceuticals Health LLC)

View source ↗

Summary

FDA approved a supplemental application for Valacyclovir by Quallent Pharmaceuticals Health LLC under ANDA203047, indicating a regulatory update to the generic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Valacyclovir (Valacyclovir)

Snippet

SUPPL AP for VALACYCLOVIR (VALACYCLOVIR)